Comunicado de prensa

Siemens advances indoor air quality innovation through ARPA-H BREATHE projects

24 de marzo de 2026
Washington, D.C., USA

  • Siemens powers healthier, smarter buildings with advanced digital twin and optimization technologies

Siemens announced its participation in the groundbreaking Advanced Research Projects Agency for Health (ARPA-H) BREATHE program, an up to five-year initiative aimed at improving indoor air quality and reducing respiratory disease incidence by at least 25%. This effort underscores Siemens’ commitment to leveraging technology for healthier, more resilient environments.

The BREATHE program intends to advance the next generation of smart and healthy buildings by developing integrated systems that will provide continual measurement and risk assessment of indoor air quality and deploy real-time interventions, like extra ventilation or disinfection, to reduce airborne threats to human health.

The BREATHE solutions consist of three technical areas – TA-1: indoor air biosensors, TA-2: respiratory risk assessment software, and TA-3: healthy building controls and system integration. Siemens plays a pivotal role in TA-2 and TA-3, integrating risk assessment models with advanced building control systems to mitigate air quality threats. These solutions will enable automation responses, such as ventilation, filtration, and disinfection, through seamless integration with building management systems.

“At Siemens, we believe that digital twin technology is the key to unlocking healthier, safer, and more adaptive indoor environments,” said Virginie Maillard, Global Head of Research in Simulation and Digital Twins for Siemens. “Our commitment to simulation-driven innovation combined with our partner’s cutting-edge biosensor empowers us to model, predict, and optimize simultaneously building performance and occupants' health, making a measurable impact on public health.”

Siemens’ contributions span two BREATHE projects, a Mayo Clinic-led initiative focusing on cutting-edge biosensors, artificial intelligence and smart air filtration systems in emergency departments, and a SafeTraces-led initiative, a closed loop, array PCR real-time risk assessment and sensor-driven mitigation system for healthy indoor air for the Defense Health Agency (DHA) hospital system.

Siemens’ digital twin technology enables comprehensive modeling of airflow, temperature, and energy consumption, providing a virtual environment to test these mitigations before deployment. Siemens’ integration of digital twin modeling and simulation and building automation, together with the cutting-edge partners’ biosensor technology, creates a closed-loop, adaptive ecosystem for healthy buildings. These capabilities ensure robust solutions validated through field trials, which will be conducted across multiple U.S. cities in critical infrastructure, to validate performance under diverse conditions.

Siemens is collaborating closely with each partner to ensure its technologies deliver measurable health benefits and operational efficiency, with a focus on rapid detection and mitigation of detected pathogens. Siemens’ solutions integrate with risk assessment models, enabling dynamic, automated building responses to real-time biosensor data.

Siemens AG (Berlín y Múnich) es una empresa líder en tecnología centrada en la industria, la infraestructura, la movilidad y la atención médica. El objetivo de la empresa es crear tecnología para transformar el día a día de todos. Al combinar el mundo real y el digital, Siemens permite a los clientes acelerar sus transformaciones digitales y de sostenibilidad, haciendo que las fábricas sean más eficientes, las ciudades más habitables y el transporte más sostenible. Como líder en inteligencia artificial industrial, Siemens aprovecha su profundo conocimiento del sector para aplicar la IA – incluida la inteligencia artificial generativa – a aplicaciones del mundo real, haciendo que la IA sea accesible y tenga un impacto significativo para los clientes en diversas industrias. Siemens también posee una participación mayoritaria en la empresa cotizada Siemens Healthineers, un proveedor líder mundial de tecnología médica que es pionero en avances en el ámbito de la atención médica. Para todos. En todas partes. De forma sostenible.

En el ejercicio fiscal 2025, que terminó el 30 de septiembre de 2025, el grupo Siemens generó ingresos por 78.9 mil millones de euros y una utilidad neta de 10.4 mil millones de euros. Al 30 de septiembre de 2025, la empresa empleaba aproximadamente a 318,000 personas en todo el mundo sobre la base de operaciones continuadas. Más información está disponible en www.siemens.com.

ARPA-H Disclaimer
This research was, in part, funded by the Advanced Research Projects Agency for Health (ARPA-H). The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the United States Government.

Contactos para prensa

Christine Whitman
Communications Professional
Phone: +1-202-316-2347
Email: christine.whitman@siemens.com